Cite
MLA Citation
Sophie Hallakou‐Bozec et al.. “Mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes.” Diabetes, obesity & metabolism, vol. 23, no. 3, 2021, pp. 664–673. http://access.bl.uk/ark:/81055/vdc_100122904476.0x00001c